Estadísticas de Angiotensin-converting-enzyme inhibitors and angiotensin II re-ceptor blockers for COVID-19: A living systematic review of randomized clinical trials
Visitas totales
views | |
---|---|
Angiotensin-converting-enzyme inhibitors and angiotensin II re-ceptor blockers for COVID-19: A living systematic review of randomized clinical trials | 0 |
Visitas totales por mes
views | |
---|---|
January 2024 | 0 |
February 2024 | 0 |
March 2024 | 0 |
April 2024 | 0 |
May 2024 | 0 |
June 2024 | 0 |
July 2024 | 0 |
Visitas de archivo
views | |
---|---|
Meza_Angi2021.pdf | 9 |